LNCD(SH:600739) Zhong Guo Jin Rong Xin Xi Wang·2025-11-21 12:49Core Viewpoint - The company, Liaoning Chengda, has decided to permanently suspend operations at Xinjiang Baoming Mining Co., Ltd. and will not provide further large cash injections, focusing instead on attracting strategic investors and shifting its focus towards core industries like biomedicine [1] Group 1: Company Strategy and Management - The new management team, elected in February, is actively optimizing the financing structure and controlling funding costs to ensure stable operations across all business segments [2] - The company has issued short-term financing bonds with decreasing interest rates, indicating a successful reduction in financing costs [2] - The management aims to enhance the company's core competitiveness and sustainable development through non-public issuance of exchangeable bonds [3] Group 2: Financial Performance and Investments - The company has seen significant growth in investment income from its holdings in Guangfa Securities and China Insurance, with year-on-year increases of 53.19% and 143.94%, respectively [4] - The capital market has rebounded, contributing to the increase in asset values and overall financial performance [4] Group 3: Focus on Biomedicine - The company has partnered with the Chinese Academy of Sciences to establish an AI-based vaccine research laboratory, aiming to enhance innovation in vaccine development [6] - Ongoing collaborations with the Chinese Academy of Microbiology focus on infectious disease prevention, with several vaccine candidates in various stages of clinical trials [7] - The company is expanding its vision beyond human vaccines to explore early-stage biopharmaceutical technologies and potential mergers and acquisitions to create a second growth curve [7]